Concepedia

L. Seigel

LS

Statistics

Publications

10

Citations

941

H-Index

10

Active since

2001

Affiliations

Holy Cross Hospital(Current)

Mount Sinai Hospital

Mount Sinai Medical Center

Sylvester Comprehensive Cancer Center

Vall d'Hebron Institute of Oncology

L. Seigel is an author at Holy Cross Hospital specializing in chemotherapy, oncology, and non-small cell lung cancer treatment.

Publications per year

2001–2021

10

Publications

10

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Sung‐Bae Kim, Rebecca Dent, Seock‐Ah Im et al. · The Lancet Oncology · 2017 · 474 citations · Full text

, , +15

Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2

Rogério Lilenbaum, Rita Axelrod, Sachdev Thomas et al. · Journal of Clinical Oncology · 2008 · 178 citations · Full text

, , +14

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Rebecca Dent, Mafalda Oliveira, Steven J. Isakoff et al. · Breast Cancer Research and Treatment · 2021 · 74 citations

, , +14

Phase II trial of weekly docetaxel in second-line therapy for nonsmall cell lung carcinoma

Rogério Lilenbaum, Michael Schwartz, L. Seigel et al. · Cancer · 2001 · 72 citations

, , +15

A Randomized Phase II Trial of Two Schedules of Docetaxel in Elderly or Poor Performance Status Patients with Advanced Non-small Cell Lung Cancer

Rogério Lilenbaum, Mark A. Rubin, Joyce P. Samuel et al. · Journal of Thoracic Oncology · 2007 · 41 citations · Full text

, , +7

1–5 of 10